NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING


Year of Award:
1999
Award Type:
R21
Project Number:
CA081658
RFA Number:
PAR-98-067
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
VIDAL, MARC
Other PI or Project Leader:
N/A
Institution:
MASSACHUSETTS GENERAL HOSPITAL
An important aspect of developing treatments against cancer consists in correcting the defects caused by the abnormal activity of oncogenes and tumor suppressor genes. This usually includes the assignment of cancer- related gene products to their respecti